TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32065644

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL) with normal saline instilled into the endotracheal tube.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 100
Study: 34311777

Group type: COMPARATOR
Intervention: Candidate treatment (specific candidates not mentioned)
Number of subjects: 6
Study: 32273054

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 142201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142201

Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor antagonists (MRAs)
Number of subjects: 142201
Study: 32722956

Group type: EXPERIMENTAL
Intervention: 100 mg/day thiamin supplements
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32968994

Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Second ARTA therapy
Number of subjects: 0
Study: 34794009

Group type: EXPERIMENTAL
Intervention: Behavior Change Communication (BCC) and food vouchers together
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavior Change Communication (BCC) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Food vouchers alone
Number of subjects: 0
Study: 33571072

Group type: EXPERIMENTAL
Intervention: Keeogo™ exoskeleton
Number of subjects: 24
Study: 32898699

Group type: EXPERIMENTAL
Intervention: N-glycans from tissue samples
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: N-glycans from serum samples
Number of subjects: 83

Group type: COMPARATOR
Intervention: N-glycans analysis
Number of subjects: 83
Study: 32491907

Group type: EXPERIMENTAL
Intervention: Randomized multifractal temporally weighted detrended fluctuation analysis (RMFTWDFA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multifractal temporally weighted detrended fluctuation analysis (MFTWDFA)
Number of subjects: 0
Study: 35290101

Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 565

Group type: COMPARATOR
Intervention: Olaparib
Number of subjects: 565

Group type: COMPARATOR
Intervention: Olaparib/Cediranib
Number of subjects: 565
Study: 34369452

Group type: EXPERIMENTAL
Intervention: Incremental vestibulo-ocular reflex (VOR) adaptation (IVA) training, once daily for 15 minutes over 6 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: x1 training, once daily for 15 minutes over 6 months
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Incremental vestibulo-ocular reflex (VOR) adaptation (IVA) training
Number of subjects: 21

Group type: COMPARATOR
Intervention: x1 training
Number of subjects: 21
Study: 32584828

Group type: EXPERIMENTAL
Intervention: Access to an online platform with personalized suggestions for prosocial actions
Number of subjects: 66

Group type: COMPARATOR
Intervention: Tracking of daily prosocial behavior
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Enjoyment of the platform
Number of subjects: 66
Study: 35437302

Group type: EXPERIMENTAL
Intervention: American Heart Association (AHA) diet
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Fatty Liver in Obesity (FLiO) diet
Number of subjects: 86

Group type: COMPARATOR
Intervention: AHA and FLiO diets
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Genetic Risk Score (GRS) model
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Genetic screening and insulin resistance markers
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Models predicting changes on Triglycerides and Glucose (TyG) index and Retinol‐binding protein 4 (RBP4) levels
Number of subjects: 86
Study: 34162649

Group type: EXPERIMENTAL
Intervention: Medial unicompartmental arthroplasty
Number of subjects: 143

Group type: COMPARATOR
Intervention: Total knee arthroplasty
Number of subjects: 143
Study: 33203635

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing for Maternal Immunisation strategy (MI4MI)
Number of subjects: 0
Study: 35207224

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS over the right dorsolateral prefrontal cortex (n = 14)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS (n = 16)
Number of subjects: 30
Study: 33158419

Group type: EXPERIMENTAL
Intervention: Face-to-face reminder by the GP
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Digital reminders targeted at patients with increased CMD risk
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sending invitations and reminders by e-mail
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Translated materials, information gatherings at the practice, self-management toolkits, reminders by telephone, information letters, local media attention, SMS text reminders
Number of subjects: 29
Study: 35852024

Group type: EXPERIMENTAL
Intervention: Smaller bottles (37.5cl)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Smaller glasses (290ml)
Number of subjects: 260
Study: 34308962

Group type: EXPERIMENTAL
Intervention: Smoking (increased consumption of cigarettes per day by 1 standard deviation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Binary smoking status
Number of subjects: 0
Study: 32938386

Group type: EXPERIMENTAL
Intervention: Dezocine 0.03 mg/kg (diluted to 5 mL)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 210
Study: 33870714

Group type: EXPERIMENTAL
Intervention: Postprandial palmitate appearance (Rapalmitate) in IGT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rapalmitate from obesity‐associated increase in intracellular lipolysis in IGT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rapalmitate from DFA spillover in IGT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Visceral AT DFA trapping in IGT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Plasma glycerol appearance in IGT
Number of subjects: 60
Study: 36181076

Group type: EXPERIMENTAL
Intervention: Qigong exercise program for 12 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 125
Study: 34601233

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (1-hour education session and daily mindfulness exercises during hospitalization)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (no mindfulness intervention)
Number of subjects: 158
Study: 33370962

Group type: EXPERIMENTAL
Intervention: Robotic sleeve gastrectomy
Number of subjects: 1
Study: 33250216

Group type: EXPERIMENTAL
Intervention: Extended spectrum penicillins during the first trimester
Number of subjects: 359

Group type: COMPARATOR
Intervention: Control group (no extended spectrum penicillins)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Maternal obesity and diabetes
Number of subjects: 359

Group type: COMPARATOR
Intervention: History of multiple miscarriages
Number of subjects: 359
Study: 34114615

Group type: EXPERIMENTAL
Intervention: Serum inflammatory markers (IL‐1β, ‐2, ‐4, ‐6, ‐8, ‐17 A, ‐17 F, ‐21, ‐22 and ‐23)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Serum inflammatory markers (IL‐10, ‐12 and GM‐CSF)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Serum markers (Leptin, adipsin and CRP)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Serum marker (Resistin)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Serum markers (Apelin‐36 and adiponectin)
Number of subjects: 200
Study: 34626915

Group type: EXPERIMENTAL
Intervention: Psycho-behavioural intervention (PBI)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Health education program (Control)
Number of subjects: 19
Study: 35045227

Group type: EXPERIMENTAL
Intervention: Closed-loop system
Number of subjects: 74
Study: 34793637

Group type: EXPERIMENTAL
Intervention: 10 mL of ropivacaine 0.5% (experimental group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 15 mL of ropivacaine 0.5% (control group)
Number of subjects: 52
Study: 34546360

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: Upadacitinib
Number of subjects: 858

Group type: COMPARATOR
Intervention: Clinical remission (defined as SF ≤2.8, AP score ≤1.0)
Number of subjects: 858

Group type: COMPARATOR
Intervention: Clinical parameters (SF and AP)
Number of subjects: 858
Study: 34584203

Group type: EXPERIMENTAL
Intervention: anti-PD1 treatment
Number of subjects: 81
Study: 34171233

Group type: EXPERIMENTAL
Intervention: PCV10 vaccination schedule (3+1) at ages 2, 3, 4, and 9 months (group A)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: PCV10 vaccination schedule (3+0) at ages 2, 3, and 4 months (group B)
Number of subjects: 1201

Group type: COMPARATOR
Intervention: PCV10 vaccination schedule (2+1) at ages 2, 4, and 9.5 months (group C)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: PCV10 vaccination schedule (two-dose) at ages 2 and 6 months (group D)
Number of subjects: 1201
Study: 32370765

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR) + standard of care (SOC) treatments
Number of subjects: 297

Group type: COMPARATOR
Intervention: Standard of care (SOC) palliative-intent treatments
Number of subjects: 297
Study: 34875624

Group type: EXPERIMENTAL
Intervention: Evening whey protein supplement
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32579616

Group type: EXPERIMENTAL
Intervention: Functional support (measured by DUFSS)
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Functional support (medium vs. low tertile)
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: IUVs (less than four)
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQOL perception)
Number of subjects: 593
Study: 34098771

Group type: EXPERIMENTAL
Intervention: Alprostadil + hydration
Number of subjects: 1146

Group type: COMPARATOR
Intervention: Control (simple hydration treatment)
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Alprostadil treatment
Number of subjects: 1146
Study: 33571453

Group type: EXPERIMENTAL
Intervention: Prognosis-matched care (intervention group)
Number of subjects: 1671

Group type: COMPARATOR
Intervention: Usual care plus attention control (control group)
Number of subjects: 1671

Group type: EXPERIMENTAL
Intervention: Prognosis-matched care (intervention group) in severe prognostic group
Number of subjects: 1671

Group type: EXPERIMENTAL
Intervention: Prognosis-matched care (intervention group) in severe prognostic group (complier average causal effect analysis)
Number of subjects: 1671
Study: 32157623

Group type: EXPERIMENTAL
Intervention: Tailored Information Program for Safer Sex (computer‐tailored intervention)
Number of subjects: 274
Study: 35988576

Group type: EXPERIMENTAL
Intervention: Upadacitinib 45 mg once-daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once-daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg once-daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34293127

Group type: EXPERIMENTAL
Intervention: Low-sodium DASH diet (1150 mg sodium)
Number of subjects: 412

Group type: COMPARATOR
Intervention: High-sodium control diet (3450 mg sodium)
Number of subjects: 412
Study: 32162310

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 3694
Study: 35956264

Group type: EXPERIMENTAL
Intervention: High fruit and vegetable diet (F&V) for 6 months
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (usual diet) for 6 months
Number of subjects: 47
Study: 36276376

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS) based on clinical parameters (age, race, marital status, TNM stage, tumor size, surgery)
Number of subjects: 3528

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 3528

Group type: EXPERIMENTAL
Intervention: Risk classification system for patients with pRCC
Number of subjects: 3528
Study: 32018065

Group type: EXPERIMENTAL
Intervention: Schema therapy
Number of subjects: 320

Group type: COMPARATOR
Intervention: Clarification‐oriented psychotherapy
Number of subjects: 320

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 320
Study: 35603908

Group type: EXPERIMENTAL
Intervention: ertugliflozin
Number of subjects: 0
Study: 33629508

Group type: EXPERIMENTAL
Intervention: Meat and fast food dietary pattern
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: Fish and vegetables dietary pattern
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: Starchy foods dietary pattern
Number of subjects: 1401
Study: 32161366

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (IN‐OT) administration (24 IU/day for 4 weeks)
Number of subjects: 38
Study: 33812487

Group type: EXPERIMENTAL
Intervention: Dolutegravir, emtricitabine, and tenofovir alafenamide fumarate
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Dolutegravir, emtricitabine, and tenofovir disoproxil fumarate
Number of subjects: 643

Group type: COMPARATOR
Intervention: Efavirenz, emtricitabine, and tenofovir disoproxil fumarate
Number of subjects: 643
Study: 32023313

Group type: EXPERIMENTAL
Intervention: Standing for 12.2 ± 0.1 h
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sitting for 14.4 ± 0.3 h
Number of subjects: 18
Study: 35358395

Group type: EXPERIMENTAL
Intervention: NO3‐‐rich beetroot juice (BRnitrate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: NO3‐‐depleted beetroot juice (BRplacebo)
Number of subjects: 12
Study: 33596412

Group type: EXPERIMENTAL
Intervention: WiSE system (leadless endocardial system) for cardiac resynchronization therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional epicardial left ventricular lead (implied control)
Number of subjects: 0
Study: 32580161

Group type: EXPERIMENTAL
Intervention: Nordic hamstring exercise training performed twice a week (n = 17)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Nordic hamstring exercise training performed once a week (n = 15)
Number of subjects: 32
Study: 33567883

Group type: EXPERIMENTAL
Intervention: Virtual Interview Training for Transition Age Youth
Number of subjects: 71

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 71
Study: 32163573

Group type: EXPERIMENTAL
Intervention: High Body Mass Index (BMI)
Number of subjects: 12403

Group type: COMPARATOR
Intervention: Genetic risk of PCOS
Number of subjects: 12403
Study: 32969758

Group type: EXPERIMENTAL
Intervention: Reldesemtiv 150 mg bid
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Reldesemtiv 300 mg bid
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Reldesemtiv 450 mg bid
Number of subjects: 458

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Reldesemtiv (all doses combined)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Reldesemtiv
Number of subjects: 458
Study: 32474564

Group type: EXPERIMENTAL
Intervention: 24h-SIRI/B (oral S-1 with 24-h infusion of irinotecan plus bevacizumab)
Number of subjects: 120

Group type: COMPARATOR
Intervention: FOLFIRI/B (FOLFIRI plus bevacizumab)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 24h-SIRI/B
Number of subjects: 120

Group type: COMPARATOR
Intervention: FOLFIRI/B
Number of subjects: 120
Study: 35989681

Group type: EXPERIMENTAL
Intervention: Family Strengthening Intervention for Refugees (FSI‐R)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 80
Study: 34454161

Group type: EXPERIMENTAL
Intervention: Family-centered cesarean (Method 1)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Traditional cesarean (Method 2)
Number of subjects: 129
Study: 32836059

Group type: EXPERIMENTAL
Intervention: With feedback (internal or external)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Without feedback
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: MOCS (Method of Constant Stimuli)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Adaptive staircase
Number of subjects: 140
Study: 34716036

Group type: EXPERIMENTAL
Intervention: Participant-led engagement behaviors
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Counselor-led engagement behaviors
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: General engagement behaviors
Number of subjects: 37
Study: 33222171

Group type: EXPERIMENTAL
Intervention: Pathogen-reduced RBCS
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gamma-irradiated RBCS
Number of subjects: 50
Study: 34613338

Group type: EXPERIMENTAL
Intervention: Genetically lower level of non-HDL cholesterol (17 mg/dL)
Number of subjects: 102607
Study: 34946289

Group type: EXPERIMENTAL
Intervention: Intervention-1 (IG-1): Complementary training with traditional means of physical therapy
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Intervention-2 (IG-2): Complementary training with mechanical devices
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 97
Study: 33407747

Group type: EXPERIMENTAL
Intervention: 25% albumin infusion
Number of subjects: 65

Group type: COMPARATOR
Intervention: 0.9% sodium chloride infusion
Number of subjects: 65
Study: 32041615

Group type: EXPERIMENTAL
Intervention: Communication skills training program based on the couple focused approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 35870895

Group type: EXPERIMENTAL
Intervention: Weekly physical activity (PA) scheduled
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Weekly energisers (short classroom PA breaks) scheduled
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Proposed support sustainability strategy - provision of PA equipment packs
Number of subjects: 134
Study: 33782701

Group type: EXPERIMENTAL
Intervention: 30-day smartphone ECG monitoring (KardiaMobile)
Number of subjects: 203

Group type: COMPARATOR
Intervention: 24-h Holter monitoring
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: 30-day smartphone ECG monitoring
Number of subjects: 203
Study: 32826188

Group type: EXPERIMENTAL
Intervention: MMA injections combined with corticosteroids (ropivacaine, morphine, methylprednisolone)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 50
Study: 36123067

Group type: EXPERIMENTAL
Intervention: CytoSorb haemoadsorption along with standard surgical treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard surgical treatment alone
Number of subjects: 36
Study: 32727624

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 4002

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Oxygen (HFNO)
Number of subjects: 4002

Group type: COMPARATOR
Intervention: Standard care (oxygen delivered by face mask or nasal cannula)
Number of subjects: 4002
Study: 35874968

Group type: EXPERIMENTAL
Intervention: Immediate-use App group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Delayed-use App group
Number of subjects: 200
Study: 32891115

Group type: EXPERIMENTAL
Intervention: Ipsilateral tilt position (n = 109)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Supine position (n = 107)
Number of subjects: 216
Study: 34813973

Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs)
Number of subjects: 12
Study: 34521597

Group type: EXPERIMENTAL
Intervention: Bicycle distribution program
Number of subjects: 525
Study: 33616575

Group type: EXPERIMENTAL
Intervention: Acupuncture at local acupoints (head, neck)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Acupuncture at distal acupoints (hands, legs, feet)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (nontreated patients from the waiting list)
Number of subjects: 102
Study: 34806246

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Supportive expressive dynamic psychotherapy (SEDP)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 215
Study: 33091586

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 0
Study: 33417476

Group type: EXPERIMENTAL
Intervention: Cryoballoon
Number of subjects: 200

Group type: COMPARATOR
Intervention: Laserballoon
Number of subjects: 200
Study: 32380893

Group type: EXPERIMENTAL
Intervention: 8-week inter-donation interval
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: 12-week inter-donation interval
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: Utility score maximization
Number of subjects: 20000
Study: 36167573

Group type: EXPERIMENTAL
Intervention: Oral co-trimoxazole 960 mg once daily for 18 months
Number of subjects: 432

Group type: COMPARATOR
Intervention: Placebo once daily for 18 months
Number of subjects: 432
Study: 34444682

Group type: EXPERIMENTAL
Intervention: SOFB (sprouted oat fermented beverage)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo beverage (control)
Number of subjects: 10
Study: 33108030

Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT) with adherence support, walking/running 4 × 4 minutes at 90% of peak heart rate, 2 days/week for 1 year.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (CG) given 2 introductory AIT sessions and advised to continue training.
Number of subjects: 48
Study: 35861446

Group type: EXPERIMENTAL
Intervention: Subcutaneous hydration (hypodermoclysis)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Intravenous hydration
Number of subjects: 26
Study: 33389651

Group type: EXPERIMENTAL
Intervention: 153Sm-hydroxyapatite
Number of subjects: 40

Group type: COMPARATOR
Intervention: 90Y-hydroxyapatite
Number of subjects: 40
Study: 32459631

Group type: EXPERIMENTAL
Intervention: Mobile-delivered, coach-guided DPP (Noom)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (usual medical care)
Number of subjects: 202
Study: 36305633

Group type: EXPERIMENTAL
Intervention: CJM112 300 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: CJM112 75 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33118696

Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS)
Number of subjects: 1845

Group type: COMPARATOR
Intervention: Xience everolimus-eluting stent (EES)
Number of subjects: 1845
Study: 32304353

Group type: EXPERIMENTAL
Intervention: Zhong-Yong thinking based DBT group skills training (DBTZYT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Supportive group therapy (SGT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Wait-list group (WL)
Number of subjects: 97
Study: 36241889

Group type: EXPERIMENTAL
Intervention: Moraceae with CHX mouthwash
Number of subjects: 30

Group type: COMPARATOR
Intervention: CHX-alone mouthwash
Number of subjects: 30